These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25735345)

  • 1. Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer.
    Zhong YH; Peng H; Cheng HZ; Wang P
    Asian Pac J Cancer Prev; 2015; 16(3):1139-43. PubMed ID: 25735345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
    Yang J; Niu H; Huang Y; Yang K
    PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
    Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic effects of
    Xia L; Zhang W; Gao L
    Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
    Ye M; Huang T; Li J; Zhou C; Yang P; Ni C; Chen S
    Medicine (Baltimore); 2017 Jan; 96(4):e5956. PubMed ID: 28121942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of association between E-cadherin promoter methylation and lung cancer risk].
    Zeng Y; Liu R; Zhang H
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):353-8. PubMed ID: 23866665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer.
    Zhai X; Li SJ
    Asian Pac J Cancer Prev; 2014; 15(12):4925-8. PubMed ID: 24998565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer.
    Wang L; Lin YL; Li B; Wang YZ; Li WP; Ma JG
    J Int Med Res; 2014 Oct; 42(5):1085-92. PubMed ID: 25015764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis.
    Chen F; Huang T; Ren Y; Wei J; Lou Z; Wang X; Fan X; Chen Y; Weng G; Yao X
    BMC Urol; 2016 Aug; 16(1):52. PubMed ID: 27578166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Methylation of FHIT and CDH13 Gene Promoter Region and Liver Cancer.
    Tuoya AD; Wang DX; Xing YS; Liu RJ; Hu YX; Zhang MD; Bai TY; Lv XL; Li J; Chang FH
    Curr Med Sci; 2020 Jun; 40(3):502-509. PubMed ID: 32474857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
    Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
    Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.
    Sun D; Zhang Z; Van do N; Huang G; Ernberg I; Hu L
    Oral Oncol; 2007 Jan; 43(1):82-7. PubMed ID: 16807071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
    Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation pattern of CDH13 gene in digestive tract cancers.
    Hibi K; Kodera Y; Ito K; Akiyama S; Nakao A
    Br J Cancer; 2004 Sep; 91(6):1139-42. PubMed ID: 15292927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.
    Huang YZ; Wu W; Wu K; Xu XN; Tang WR
    Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.
    Ulivi P; Zoli W; Calistri D; Fabbri F; Tesei A; Rosetti M; Mengozzi M; Amadori D
    J Cell Physiol; 2006 Mar; 206(3):611-5. PubMed ID: 16222700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin gene methylation in lung cancer.
    Liu ZL; Wang Q; Huang LN
    Tumour Biol; 2014 Sep; 35(9):9027-33. PubMed ID: 24906605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
    Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
    Br J Cancer; 2004 Mar; 90(5):1030-3. PubMed ID: 14997203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.